Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Lithera appoints George Mahaffey as president and CEO

This article was originally published in Scrip

Executive Summary

George Mahaffey has been named president and chief executive officer of Lithera; he will also join the company's board of directors. Dr John Dobak, founder and CEO of Lithera since its inception in 2007, will remain on the board of directors. Mr. Mahaffey has 24 years' pharmaceutical and biotechnology industry experience, having most recently served as CEO of Peplin after the dermatology company's acquisition by LEO Pharma in 2009. Lithera is a clinical-stage company developing pharmaceutical and biomedical products for medical and lifestyle indications in ophthalmology and aesthetic medicine. The company's lead injectable product candidate, LIPO-102, is designed to produce local, selective fat tissue reduction (pharmaceutical lipoplasty).

Advertisement

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

SC012360

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel